US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

US IPOs and Secondary Offerings

IPOs and Secondary Offerings

Equity Capital Markets

Kestra Medical Technologies / Equity Capital Markets

<ul>
<li>The company, which debuted in March 2025 with 11.9 million shares priced at $17.00—above its $14–$16 range—opened at $22.95 for a 35% gain.</li>
<li>Following its debut, Kestra Medical Technologies (KMTS US)  hit an early post-IPO high of $26.15 but traded as low as $13.25 in the summer.</li>
<li>The stock has jumped in the last month on the heels of strong first-quarter financial results, where the company not only beat revenue expectations but also raised full-year guidance.</li>
</ul>


The company, which debuted in March 2025 with 11.9 million shares priced at $17.00—above its $14–$16 range—opened at $22.95 for a 35% gain.
Following its debut, Kestra Medical Technologies (KMTS US)  hit an early post-IPO high of $26.15 but traded as low as $13.25 in the summer.
The stock has jumped in the last month on the heels of strong first-quarter financial results, where the company not only beat revenue expectations but also raised full-year guidance.


ケストラ・メディカル・テクノロジーズ（KMTS）6ヶ月サマリー：セクター変動のなか着実な回復